Add to ORKGSummary: A review of hospital records for the years 1980-81 has revealed that 10 % of the cases receiving a combination of isoniazid, pyrazinamide and rifampicin, with or without other anti-tuber-cutosis drugs, administered daily, had developed hepatitis. In addition, Two of the 10 patients receiving isoniazid and rifampicin daily in combination with other anti-tuberculosis drugs had developed hepatitis, the overall prevelence of jaundice in those receiving rifampicin therapy being 11.4 % (8 out of 70 cases). Jn contrasl, none of the cases receiving isoniazid and pyra2inamide in the same doses in conjunction with other anti-tuberculosis drugs daily had developed hepatitis. It is concluded that addition of rifampicin to anti-tuberculosis che...
Control noted that the reported incidence of isoniazid-associated liver disease in a population rece...
Timely and intensive monitoring for, and management of, adverse effects caused by anti-tuberculosis ...
Background: Drug-induced hepatotoxicity (DIH) is the most common adverse drug reaction leading to in...
Results are presented of the incidence of hepatitis, nearly always with jaundice, among 1686 patien...
SETTING: Drug-induced hepatitis is known to occur in a proportion of patients on treatment for activ...
A 42-year-old Indian man received 450 mg rifampicin (RIF) and 150 mg isoniazid (INH) daily after bei...
Tuberculosis (TB) is a chronic bacterial infection caused by Mycobacterium tuberculosis complex, mos...
Tuberculosis (TB) is a great health problem worldwide,and the most effective control method is to cu...
Background and Rationale. Among the adverse events related to tuberculosis treatment, hepatotoxicity...
Isoniazid and pyrazinamide are both well-known hepatotoxic drugs. When isoniazid is used, the hepati...
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. About...
BackgroundShort-course chemotherapy comprising isoniazid, rifampicin, ethambutol, and pyrazinamide h...
Objective: The aim of this study was to determine the frequency of anti-tuberculous therapy (ATT) in...
Recent increases in the dosages of the essential antituberculosis agents isoniazid (INH), rifampicin...
Hepatotoxicity is the main concern during tuberculosis chemotherapy with the first-line drugs isonia...
Control noted that the reported incidence of isoniazid-associated liver disease in a population rece...
Timely and intensive monitoring for, and management of, adverse effects caused by anti-tuberculosis ...
Background: Drug-induced hepatotoxicity (DIH) is the most common adverse drug reaction leading to in...
Results are presented of the incidence of hepatitis, nearly always with jaundice, among 1686 patien...
SETTING: Drug-induced hepatitis is known to occur in a proportion of patients on treatment for activ...
A 42-year-old Indian man received 450 mg rifampicin (RIF) and 150 mg isoniazid (INH) daily after bei...
Tuberculosis (TB) is a chronic bacterial infection caused by Mycobacterium tuberculosis complex, mos...
Tuberculosis (TB) is a great health problem worldwide,and the most effective control method is to cu...
Background and Rationale. Among the adverse events related to tuberculosis treatment, hepatotoxicity...
Isoniazid and pyrazinamide are both well-known hepatotoxic drugs. When isoniazid is used, the hepati...
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. About...
BackgroundShort-course chemotherapy comprising isoniazid, rifampicin, ethambutol, and pyrazinamide h...
Objective: The aim of this study was to determine the frequency of anti-tuberculous therapy (ATT) in...
Recent increases in the dosages of the essential antituberculosis agents isoniazid (INH), rifampicin...
Hepatotoxicity is the main concern during tuberculosis chemotherapy with the first-line drugs isonia...
Control noted that the reported incidence of isoniazid-associated liver disease in a population rece...
Timely and intensive monitoring for, and management of, adverse effects caused by anti-tuberculosis ...
Background: Drug-induced hepatotoxicity (DIH) is the most common adverse drug reaction leading to in...